-
Digitek Digoxin Recall: Tablets May Be Double The Normal Dose
So-called "Digitalis Toxicity" Is Possible, Especially In Patients With Renal Failure (Posted by Tom Lamb at DrugInjuryWatch.com) In an April 28, 2008 MedWatch Safety Alert about Digitek (digoxin tablets), the FDA informed doctors and…
-
FDA’s 2007 Report On Outstanding Post-approval Studies: No Progress Made By Big Pharma
After Their Medications Get Approved By FDA, Many Drug Companies Have Not Yet Started The Studies Which They Promised To Do (Posted by Tom Lamb at DrugInjuryWatch.com) Each year the FDA issues what could…
-
April 2008 Accutane Trial In New Jersey Ends With Plaintiff Verdict
Utah Woman Developed Inflammatory Bowel Disease After Using This Hoffman-LaRoche Drug (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ Update: Roche Wins Reversal of $10.5 Million Accutane Verdict in New Jersey Case By Jef Feeley…
-
April 2008: FDA Web Site Adds Two New Pages For Learning About Drug Safety
Some Important Terms Are Defined And Various Research Resources From FDA Are Listed (Posted by Tom Lamb at DrugInjuryWatch.com) On April 11, 2008 the FDA added to its web site one page that gives…
-
Ortho Evra, Preemption, And The New York Times: Another Drug Company Response Letter
And, We Learn About More Of Merck’s Vioxx Shenanigans — Another Benefit Of Pharmaceutical Product Liability Litigation (Posted by Tom Lamb at DrugInjuryWatch.com) For the second time in as many weeks, it was the…
